#11: zantriocom: Zantrio.com Stock Picks for May 19, 2009
(WYE) - shortDOJ and 16 states are joining two whistleblower suits alleging Wyeth... |
May 19, 2009
08:45:19 AM |
#10: Stock News Bot: WYE News Fitch Rates Wyeth's New Sr. Unsecured Notes 'A-'
CHICAGO--(BUSINESS WIRE)--Fitch Ratings has assigned 'A-' rating to Wyeth's... |
March 22, 2007
09:23:00 AM |
#9: Stock News Bot: WYE News Siemens Medical Solutions Collaborates with Wyeth to Advance Development of New Alzheimer's Therapies
HOFFMAN ESTATES, Ill. & COLLEGEVILLE, Pa.--(BUSINESS WIRE)--The Molecular Imaging... |
March 5, 2007
06:00:00 AM |
#8: Stock News Bot: WYE News Inovio Biomedical Grants Wyeth Pharmaceuticals License to Develop Infectious Disease DNA Vaccines
SAN DIEGO--(BUSINESS WIRE)--Inovio Biomedical Corp. (AMEX: INO), a leader in... |
November 7, 2006
12:00:00 AM |
#7: Stock News Bot: WYE News Progenics Earns $5 Million from Wyeth for Achieving Methylnaltrexone Milestone
TARRYTOWN, N.Y.--(BUSINESS WIRE)--Progenics Pharmaceuticals, Inc. (NASDAQ: PGNX)... |
October 25, 2006
02:00:00 AM |
#6: Stock News Bot: WYE News Progenics and Wyeth Initiate Global Phase 3 Clinical Program of Intravenous Methylnaltrexone to Treat Post-Operative Ileus
TARRYTOWN, N.Y. & MADISON, N.J.--(BUSINESS WIRE)--Sept. 20, 2006--Progenics... |
September 19, 2006
09:05:00 PM |
#5: Stock News Bot: WYE News Wyeth and Progenics Announce Methylnaltrexone Receives FDA Fast Track Designation for Treatment of Postoperative Ileus
MADISON, N.J. & TARRYTOWN, N.Y.--(BUSINESS WIRE)--July 17, 2006--Wyeth... |
July 17, 2006
02:00:00 AM |
#4: Stock News Bot: WYE News Wyeth and Progenics Pharmaceuticals Announce Worldwide Collaboration to Develop and Commercialize Methylnaltrexone; Methylnaltrexone in Late-Stage Clinical Development for Opioid-Induced Constipation and Post-Operative Bowel Dysfunction
MADISON, N.J. & TARRYTOWN, N.Y.--(BUSINESS WIRE)--Dec. 23, 2005--Wyeth... |
December 22, 2005
11:00:00 PM |
#3: Stock News Bot: WYE News SCOLR Pharma Announces Worldwide Licensing Agreement with Wyeth Consumer Healthcare
BELLEVUE, Wash.--(BUSINESS WIRE)--Dec. 22, 2005--SCOLR Pharma, Inc. (Amex: DDD)... |
December 22, 2005
02:00:00 AM |
#2: Stock News Bot: WYE News Treatment Has Demonstrated Improvement in Physical Function and Kept Joint Damage from Progressing at Three Years
THOUSAND OAKS, Calif. & COLLEGEVILLE, Pa.--(BUSINESS WIRE)--Nov. 13, 2005-- ... |
November 13, 2005
02:30:00 PM |
#1: Stock News Bot: WYE News Teva and Wyeth Announce Settlement of Effexor XR(R) Litigation
JERUSALEM--(BUSINESS WIRE)--Oct. 18, 2005--Teva Pharmaceutical Industries Ltd.... |
October 18, 2005
10:15:00 AM |
